To determine the effects of Lactobacillus plantarum strain HSK201 on Japanese cedar pollinosis, a singleblind, placebo-controlled study was conducted in 2008. The HSK201 group was administered fermented milk prepared with HSK201 for 8 weeks, and the placebo group was administered non-fermented milk adjusted to the same acidity and taste. We found HSK201 strain intake to suppress both helper T cell type 1/2 ratio reduction and serum Japanese cedar pollen-specific IgE elevation at the peak of pollen dispersion. In addition, the nasal and ocular symptom scores in the HSK201 group were also lower than those in the placebo group during the early phase of the pollen season. Although this was a preliminary study with 19 employees of our own company serving as subjects, the results suggest that ingestion of the HSK201 strain alleviates pollinosis symptoms during the period when pollen exposure is low and the symptoms are mild.
In Japan, except in some regions such as Hokkaido and Okinawa, the highest level of dispersal of Japanese cedar pollen occurs from about February to May each year. Inhalation of Japanese cedar pollen induces allergic symptoms including sneezing, runny nose, stuffy nose, itchy eyes, and watery eyes. The prevalence of Japanese cedar pollinosis has increased by more than 15% in Japan, and hence the decrease in quality of life during the pollen season is a social concern.
It is important to avoid inhalation of Japanese cedar pollen antigen to prevent the symptoms, but complete avoidance is not possible in daily life. It has been recommended that patients with severe symptoms start drug therapy soon after pollen dispersal begins or at the onset of symptoms. 1) Antihistamines, antileukotrienes, chemical mediator release inhibitors, local steroids, etc., have been used in the control of pollinosis, depending on the severity of the symptoms. Since it is necessary to continue pharmacotherapy until the pollen dispersal level decreases, treatment often becomes expensive for the patients. In addition, the risk of side effects, such as sleepiness and thirst, also increases.
A number of reports have indicated that allergic diseases can be alleviated by ingestion of lactic acid bacteria or bifidobacteria, which are non-pathogenic and useful in the realm of food processing. Administering Lactobacillus GG prenatally to mothers with allergic relation and postnatally to their children was effective in the prevention of early atopic disease in children.
2) In addition, several studies have indicated that administration of lactic acid bacteria produces relief of allergic diseases, including allergy rhinitis, atopic eczema, and food allergy. [3] [4] [5] [6] [7] [8] With regard to Japanese cedar pollinosis, the Bifidobacterium longum BB536, 9, 10) the Lactobacillus paracasei KW3110, 11) and the Lactobacillus acidophilus L-92 12) strains have been found to suppress subjective symptoms and/or to modulate immunological parameters. On the other hand, it has been reported that oral administration of Lactobacillus GG has no effect on birch pollen allergy. 13) It has been indicated by the results of in vitro studies that the ability of lactic acid bacteria to modulate cytokine production depends on the strain rather than the species of bacteria; in other words, not all strains belonging to the same species have equal capability to modulate immune responses. 14, 15) HSK201 strongly induces interleukin (IL)-12 production and suppresses IL-4 secretion from ovalbumin-sensitized mouse splenocytes cultured with antigen (unpublished results). Hence it was expected that administration of HSK201 might be effective in the control of allergic diseases by modulating the helper T cell (Th) 1/Th2 balance. In this study, we investigated the effects of administration of fermented milk containing HSK201 on symptom scores and immunological parameters in pollinosis subjects during the Japanese cedar pollen dispersal season of 2008.
Materials and Methods
Subjects. Nineteen subjects who had symptoms of Japanese cedar pollinosis participated in the study. Prior to the pollen dispersal season, all the subjects were confirmed to be seropositive for IgE specifically directed against Japanese cedar pollen (>0:34 unit allergen (UA)/ml). All of the subjects were employees of the R&D center of Nippon Meat y To whom correspondence should be addressed. Tel: +81-29-847-7817; Fax: +81-29-847-7824; E-mail: t.hasegawa@nipponham.co.jp Abbreviations: HSK201, Lactobacillus plantarum strain HSK201; IL, interleukin; Th, helper T cell; UA, unit allergen; ECP, eosinophil cationic protein; FEIA, fluorescence enzyme immunoassay; MS, medication score; SMS, symptom-medication score Packers, Inc., and lived in Ibaraki Prefecture, Japan. All provided written informed consent for participation in the study. This study was performed in accordance with the Declaration of Helsinki, and was approved by the Local Ethics Committee of Nippon Meat Packers, Inc.
Study design. A single-blind, placebo-controlled design was used. The subjects were divided into two groups based on serum level of cedar pollen-specific IgE: an HSK201 group (n ¼ 10) and a placebo group (n ¼ 9). The HSK201 group was administered fermented milk prepared using HSK201 (containing 6 Â 10 10 CFU/170 ml) for 8 weeks. The fermented milk was stored frozen after manufacture, and the number of living bacteria was maintained until the end of the ingestion period. The placebo group was administered the same amount of non-fermented milk composed of the same materials as the fermented milk. The non-fermented milk was adjusted to the same acidity and taste using lactic acid. No particular timing of daily ingestion was specified. Blood sampling was carried out at weeks À1, 4, and 8 after the start of milk administration. The severity of the symptoms and the use of medication were analyzed each week. The study schema is shown in Fig. 1 .
Blood examination. Analysis of the serum levels of total IgE, Japanese cedar pollen-specific IgE, and eosinophil cationic protein Evaluation of the symptoms of the subjects. The symptom scores and medication scores were evaluated in accordance with the Practical Guideline for the Management of Allergic Rhinitis in Japan.
1) The subjects performed self-evaluation of the severity of the symptoms of sneezing, runny nose, stuffy nose, itchy eyes, and watery eyes on a scale of 0 to 4 ( Table 1 ). All the subjects were allowed to take medication for any symptoms. The medication score (MS) was assigned on the basis of the drug categories ( Table 2 ). The highest scores for nasal and ocular symptoms were used as the nasal and ocular symptom scores respectively, and the nasal symptom-medication score (SMS) and ocular SMS were calculated as the sums of the respective symptom and medication scores.
Statistical analysis. The Mann-Whitney U test and Wilcoxon's signed rank test were used to analyze between-group and within-group differences respectively. p-values < 0:05 were considered to denote statistical significance. Data were analyzed using SPSS software, version 14.0J (SPSS, Chicago, IL).
Results
Baseline characteristics of the subjects The study was completed for all of the 19 subjects. The baseline characteristics of the subjects at week À1 are shown in Table 3 . There were no significant differences in the age, serum levels of total IgE or Japanese cedar pollen-specific IgE, serum ECP, or the proportion of Th1 and Th2 cells between the two groups at week À1.
Serum total IgE and Japanese cedar pollen-specific IgE
The time-course of changes in the serum levels of total IgE and Japanese cedar pollen-specific IgE are shown in Fig. 2 . No significant changes in the serum levels of total IgE were observed in either group throughout the study period. On the other hand, the (HSK201 group n = 10 , Placebo group n = 9) Fig. 1 . Study Schema. 
. As compared with the serum level of ECP at week À1, the level at week 8 was elevated in both groups, whereas a significant difference was noted only in the placebo group (p ¼ 0:021). There were no significant intergroup differences in the percentages of Th1 and Th2 cells, the Th1/Th2 ratio, or the serum ECP level between the two groups (Fig. 3) .
Subjective symptoms
Induction of nasal and ocular symptoms appeared at about week 4, when pollen dispersal started (Fig. 4) . The increases in nasal SMS and nasal MS were delayed in the HSK201 group as compared with the placebo group. The maximum differences in the nasal SMS and nasal MS between the two groups were observed at week 7, although the inter-group differences were not significant. With regard to the scores for each of the nasal symptoms, the scores for sneezing (significant differences at weeks 5, 6, 7) and runny nose (significant differences at weeks 6, 7, 8) were lower in the HSK201 group. There was no significant difference in the scores for stuffy nose between the two groups. The ocular SMS was significantly lower in the HSK201 group at weeks 5, 6, 7 as compared with the placebo group. During the same period, the scores for itchy eyes (significant differences at weeks 5, 6, 7) and watery eyes (significant differences at weeks 5, 7) were also lower in the HSK201 group. Although ocular MS tended to be lower in the HSK201 group than in the placebo group even after the start of pollen dispersal, the difference did not reach statistical significance.
Discussion
In the area covered by this study, the start of cedar pollen dispersal was delayed in 2008 as compared with previous years. Pollen dispersal was observed from 4, and the level rose sharply from week 6 onward during the study. The peak of the dispersal level was observed at week 8. The total amount of pollen dispersed in this area during the spring of 2008 was about 2.3-fold greater than that during the previous spring. In Tokyo, which is within the same Kanto district, the total pollen dispersal level during the spring of 2008 was about 1.1-fold greater than the previous 10-year average. The present study design was thus deemed to be appropriate for evaluating the effects of HSK201 on the usual symptoms of pollinosis among Japanese patients.
Several studies have indicated that ingestion of lactic acid bacteria or bifidobacteria suppresses symptoms of Japanese cedar pollinosis, 9, 10, 12) but the benefit of these microorganisms in the suppression of serum specific IgE levels is still controversial. Accordingly, a noteworthy finding is that the elevation of the Japanese cedar pollenspecific IgE level in week 8 from week À1 was significant in the placebo group but suppressed in the HSK201 group. Considering a report that the serum level of specific IgE reaches its peak later than the peak of pollen dispersion, 10) we cannot rule out that the specific IgE level had not peaked at week 8 (the last point of blood sampling) of this study. However, since the placebo group showed significant elevation of the Japanese cedar-specific IgE level at week 8, these results allow us to suggest that HSK201 intake can suppress or delay elevation of the Japanese cedar pollen-specific IgE level.
To elucidate the mechanism by which HSK201 suppresses elevation of the Japanese cedar pollenspecific IgE level, we evaluated changes in the Th1/ Th2 balance. Since Th2 cells induce production of IgE antibodies via production of IL-4, changes in the Th1/ Th2 balance and the production of IgE should be considered to be related. 16) In the present study, the Th1/Th2 ratio decreased significantly after placebo intake, while it showed no significant change following HSK201 intake. Several reports have been published concerning the effects of lactic acid bacteria on the Th1/ Th2 balance. Co-culture of human PBMC and lactic acid bacteria suppressed the secretion of Th2 cytokine. 17) Ingestion of the Lactobacillus fermentum PCC strain by children with atopic dermatitis resulted in increased capacity for the IFN-response of peripheral blood mononuclear cells. 18) Ingestion of fermented milk prepared with Lactobacillus gasseri TMC0356 for 4 weeks resulted in a significant increase in the percentage of Th1 cells. 19) On the other hand, ingestion of fermented milk prepared with Lactobacillus paracasei KW3110 during the pollen season suppressed the rise in the percentage of Th2 cells. 11) Ingestion of Bifidobacterium longum BB536 suppressed elevation of the plasma level of thymus-and activation-regulated chemokine (TARC, a Th2 chemokine).
10) The results of the present study suggest that like these strains, the HSK201 strain also regulated the balance of Th cells, resulting in suppression of elevation of the Japanese cedar-specific IgE level.
Serum ECP can might be useful as a marker of inflammatory reaction associated with allergic rhinitis. [20] [21] [22] In the present study, the placebo group showed a significantly higher serum ECP level in week 8 as compared to week À1, while the HSK201 group showed insignificant elevation in this parameter. This difference in serum ECP levels also might be linked to differences in the degree of pollinosis symptoms between two groups.
As regards some symptom scores (sneezing, runny nose, itchy eyes, and watery eyes), there were significant differences between the HSK201 group and the placebo group. The significant differences were primarily seen from week 5 through week 7 of the study. At week 8, during the peak of pollen dispersal, only the score for runny nose differed significantly between the two groups. Thus the suppression of symptoms in the HSK201 group was particularly marked during the early phase of the pollen dispersal season, when the pollen level was relatively low. This suggests that it is possible to shorten the duration of severe subjective symptoms in individual patients and to obtain a significantly favorable impact from the viewpoint of improvement of the quality of life. Although MSs did not differ significantly between the HSK201 and placebo groups, the scores were relatively low in the HSK201 group even after the start of pollen dispersal, suggesting that the differences in subjective symptoms also influenced the use levels of the medications.
It is advisable to assess the anti-allergy effects separately for each strain of lactic acid bacteria. A limitation of this study was that the number of subjects was small, due to the preliminary nature of this investigation involving only our own company's employees. However, we observed that HSK201 strain intake suppressed both Th1/Th2 ratio reduction and Japanese cedar pollen-specific IgE elevation at the peak of pollen dispersion, and that these changes were accompanied by significant alleviation of pollinosis symptoms. Since the symptoms of allergy can appear under the influence of multiple factors combined, it is necessary to elucidate the mechanism of the efficacy of HSK201 in more detail. In any event, the results suggest that ingestion of the HSK201 strain alleviates pollinosis symptoms during the period when pollen exposure is low and the symptoms are mild.
